Clostridium Difficile Infection – Epidemiology – Mature Markets

DRG Epidemiology's coverage of clostridium difficile infection comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom and Japan). We report both the incidence and prevalence of clostridium difficile infection for each country, as well as annualized case counts projected to the national population.

DRG Epidemiology's clostridium difficile infection forecast will answer the following questions:

Of all people diagnosed with clostridium difficile infection, how many in each country across the major mature pharmaceutical markets are drug-treated?

How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of clostridium difficile infection over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following clostridium difficile infection patient populations:

Diagnosed Events-Hospital by Frequency

Clostridium Difficile Infection Diagnosed Events – Hospital

Clostridium Difficile Infection Diagnosed Events-Nursing Home

Comorbidities-Initial Events subpopulation(s)

Diagnosed Events-Nursing Home by Frequency

Diagnosed Events-Severity subpopulation(s)

Comorbidities-Recurrent Events subpopulation(s)

Initial Events-Severe Complicated subpopulation(s)

Initial Events-Severity subpopulation(s)

Recurrent Events-Severe Complicated subpopulation(s)

… and more (details available on request).

Note: coverage may vary by country and region.

Table of contents

  • Clostridium Difficile Infection - Epidemiology - Mature Markets
    • Introduction
      • Key Findings
        • Key Updates
      • Hospitalization Rate of Clostridium Difficile Infection per 1,000 People of All Ages in 2021 and 2031ttttttttt
      • Relative Sizes of the Factors Contributing to the Trend in Hospitalization of Clostridium Difficile Infection Over the Next 10 Years
      • Analysis of Hospitalization of Clostridium Difficile Infection in the Countries Under Study, by Stage: 2021
    • Epidemiology Data
    • Methods
      • Hospitalized Clostridium Difficile Infection
      • Hospitalized Clostridium Difficile Infection by Recurrence
      • Hospitalized Clostridium Difficile Infection by Severity
      • Healthcare-Associated Hospitalized Clostridium Difficile Infection
      • Hospital-Onset Hospitalized Clostridium Difficile Infection
      • Community-Onset Healthcare-Associated Hospitalized Clostridium Difficile Infection
      • Nursing Home-Onset Hospitalized Clostridium Difficile Infection
      • Community-Associated Hospitalized Clostridium Difficile Infection
      • Hospitalized Clostridium Difficile Infections with Comorbidities
      • Hospitalized Drug-Treated Clostridium Difficile Infection
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Clostridium Difficile Infection
        • Studies Excluded from the Analysis of Clostridium Difficile Infection
      • Risk/Protective Factors
        • Risk/Protective Factors for Clostridium Difficile Infection
      • Bibliography
      • Glossary
      • Abbreviations